| |
|
Borderline Personality Disorder:
Course, Outcomes, Interventions
|
|
Saturday, March 24, 2007
▪
Ann Arbor,
Michigan
|
|
|
|
Conference Sponsors |
The National Education Alliance for
Borderline Personality Disorder
in partnership with NARSAD
|
|
|
University of Michigan Department of Psychiatry
|
|
|
University of Michigan Depression Center
|
|
|
Wayne State University Department of Psychology
|
|
|
Michigan State University Department of Psychiatry
|
|
|
Washtenaw County Community Support and
Treatment Services
|
|
|
Livingston County Community Mental Health
|
|
|
NAMI of Washtenaw
|
|
Statement of need |
Borderline Personality disorder (BPD) is a
severe and generally chronic disorder and people who suffer
from it are underserved.
Friends and families are often bewildered and do not know
how to help.
Treatment programs for those with BPD need to be more
readily available.
Families need access to programs such as those already
developed for several other mental illnesses.
BPD presents patients, their families, clinicians, and
researchers with multiple challenges.
|
|
Purpose |
The complex
challenges associated with BPD will be addressed in order to
inform mental health professionals, families and consumers
of the most current diagnostic and treatment options
available, and other issues of current interest to those
affected by this disorder. |
|
Audience |
The Conference is for physicians, psychiatrists,
psychologists, social workers, family therapists,
counselors, nurses, emergency room personnel, law
enforcement personnel and agencies, educators, family
members, friends, and consumers.
|
|
Course description |
BPD presents clinicians and researchers,
patients and their families with multiple challenges. This one-day meeting will provide a forum for
professionals, family members, and consumers to better
understand this complex disorder from various perspectives
This conference on borderline personality disorder will
provide information about the disorder and related topics
-
Overview
-
Course of BPD
-
Biopsychology of BPD
-
Diagnostic issues
-
Suicidality
-
Parasuicidality
-
Family
and consumer perspectives
-
Family research
-
Psychopharmacology
-
Transference-focused therapy
-
Mentalization Based Psychotherapy
-
Dialectical behavior therapy
|
|
Conference
Objectives |
This
conference on borderline personality disorder will address
the following objectives and at
the end of the conference, attendees will be better able to
identify, specify, and describe:
-
The overall course and outcome of BPD (It is not as dire as
originally thought)
-
The role that emotion dysregulation plays in BPD.
-
The role of parasuicide and suicidality plays in BPD
-
How to assess and intervene in suicidality and parasuicidal
thinking in BPD
-
The difference types of evidenced based treatments that are
currently being applied to BPD including Dialectical
Behavior Therapy, Mentalization Based Therapy, and
Transference-Focused Psychotherapy
-
The role and limits of pharmacotherapy in BPD
-
Support for family and consumers with BPD
|
|
Conference
Program with Video Presentations
Click on title
of presentation to view session video. |
|
|
Welcome & Opening Remarks |
| |
Perry D. Hoffman, PhD
President, National Education
Alliance for Borderline Personality Disorder
Kenneth R. Silk, MD
Professor, Director, Personality
Disorders Program
Department of Psychiatry,
University of Michigan Health
System
Michelle
Riba, MS, MD
Professor
and Associate Chair, Dept. of Psychiatry,
University of Michigan |
|
|
|
Overview of BPD: The Clinical Presentation and
Long-term Course |
| |
Mary C. Zanarini, EdD
Director, Laboratory for the
Study of Adult Development
McLean Hospital, Belmont, Massachusetts
Associate Professor of Psychology,
Department of Psychiatry
Harvard Medical School, Boston, Massachusetts
|
| |
Mary C. Zanarini, EdD, is Director of the
Laboratory for the Study of Adult Development at
McLean Hospital in Belmont, Massachusetts, and
Associate Professor of Psychology in the
Department of Psychiatry at Harvard Medical
School. Dr. Zanarini earned her undergraduate
and doctoral degrees at Harvard College, later
completing a clinical and research fellowship in
Psychology in the Psychosocial Research Program
at McLean Hospital.
Dr. Zanarini is Chair of the NIMH Workgroup for
the Development of Guidelines for Treatment
Research on BPD and Chair of the World
Federation of Societies of Biological Psychiatry
Task Force on Personality Disorders. An active
researcher, she is currently Principal or
Co-Principal Investigator on three NIMH-funded
studies: two investigating the long-term course
of BPD and one investigating the genetics of
BPD. Through her research, she has developed
measures to assess various aspects of borderline
psychopathology such as the Diagnostic Interview
for Personality Disorders and the Zanarini
Rating Scale for DSM-IV Borderline Personality
Disorder. The National Education Alliance for
Borderline Personality Disorder presented her
with the Herb Pardes Senior Investigator Award
in 2005.
Widely published, Dr. Zanarini is a reviewer or
editorial board member of numerous scientific
journals, including Archive of General
Psychiatry, American Journal of
Psychiatry, Journal of Personality
Disorders, and Biological Psychiatry.
She is a member of the American Psychological
Association, the International Society for the
Study of Personality Disorders, the Association
for Clinical Psychosocial Research, and the
Association for Psychological Science.
|
|
|
|
Assessing and Managing the Risk
of Suicide in Patients with Borderline
Personality Disorder |
| |
Paul S.
Links, MD, FRCP(C)
Arthur Sommer Rotenberg Chair of
Suicide Studies, University of Toronto
Research Scientist, Centre for Research on Inner
City Health, St. Michael's Hospital, Toronto
Associate Member, University of Toronto, Faculty
of Medicine, Behavioural Sciences
Associate Member, Institute of Medical Science
Professor, University of Toronto, Faculty of
Medicine, Psychiatry
Deputy Chief of Psychiatry, St. Michael's
Hospital
|
| |
Professor Paul Links, of the
Department of Psychiatry, University of Toronto
is the incumbent of the Arthur Sommer Rotenberg
Chair in Suicide Studies; the first academic
Chair in North America dedicated to suicide
research. Dr. Links has formed a team of
researchers dedicated to the study of suicide,
one of the leading causes of death for people
under 35 years of age.
Dr. Links is the Deputy Chief of
Psychiatry of the St. Michael’s Hospital’s
Mental Health Service. In addition to the
Chair, he continues with his clinical work with
individuals at risk for suicide.
He has published over 75 articles
in scientific journals and two books. As a
principal investigator he has received research
grants from many agencies including the Canadian
Institutes of Health Research, Health and
Welfare Canada, the Ontario Ministry of Health
and the Ontario Mental Health Foundation. Dr.
Links is the President of the Canadian
Association for Suicide Prevention.
Dr. Links’ clinical experience
and expertise developed from working with both
acutely suicidal and persistently suicidal
patients (those who face a life-and-death
struggle on a daily basis and are at high risk
of taking their own lives).
|
|
|
|
Dialectical
Behavior Therapy |
| |
JoAnn Heap,
LMSW, ACSW
Director of Dialectical Behavior Therapy
University of Michigan Department of Psychiatry
and Washtenaw County Community Support and
Treatment Services |
|
|
|
Psychodynamic Psychotherapies for Borderline
Conditions: Transference-Focused Psychotherapy
and Mentalization-Based Psychotherapy |
| |
Frank E.
Yeomans, MD, PhD
Clinical Associate Professor of Psychiatry at
the Weill Medical College of Cornell University,
Director of Training at the Personality
Disorders Institute of the New York Presbyterian
Hospital, and Director of the Personality
Studies Institute in Manhattan.
|
| |
Dr. Yeomans is Clinical Associate Professor of
Psychiatry at the Weill Medical College of
Cornell University, Director of Training at the
Personality Disorders Institute of
Weill-Cornell, and Lecturer in Psychiatry at the
Columbia Center for Psychoanalysis. Other
positions included Unit Chief of the
Psychodynamic Unit for Borderline Conditions at
the New York Hospital-Westchester Division. More recently, Dr. Yeomans has become Director
of the Personality Studies Institute in
Manhattan. He has participated in establishing
training programs for psychodynamic therapy of
personality disorders in numerous other sites in
North America and Europe.
He has authored and co-authored numerous
articles and several books on psychotherapy
research and technique, including, with Drs.
Kernberg and Clarkin, A Primer on
Transference-Focused Psychotherapy for the
Borderline Patient, and Psychotherapy for
Borderline Personality.
|
|
|
|
Psychopharmacology: Its Effects and
Limitations |
| |
Kenneth R. Silk, MD
Professor, Director, Personality
Disorders Program
Department of Psychiatry,
University of Michigan Health
System
|
| |
Dr. Silk received his B.A. in
Biology from Brandeis University, his M.D. from
Albert Einstein College of Medicine. He did his
psychiatry residency at Yale. He is currently
Professor, Department of Psychiatry, University
of Michigan Medical School. Since 1986, he has
been Director, Personality Disorders Program.
Dr. Silk has published close to
75 scientific articles and book chapters. He
edited Biological and Neurobehavioral Studies
of Borderline Personality Disorder (American
Psychiatric Press, 1994) and Biology of
Personality Disorders (1998) in the APA’s
Annual Review of Psychiatry. He co-authored
with Allan Tasman and Michelle Riba
The Doctor-Patient Relationship in Pharmacotherapy:
Improving Treatment Effectiveness
(Guilford). He is currently in the process of
co-editing with Peter Tyrer, The Cambridge
University Press Textbook of Effective
Treatments in Psychiatry that hopefully will
be published in the late summer/early fall of
2007.
He is Secretary-Treasurer of the
International Society for the Study of
Personality Disorders. He is a Past-President
and Treasurer of the Association for Research in
Personality Disorders. He is immediate Past
President of the Michigan Psychiatric Society
and serves on the Annual Meeting Scientific
Program Committee for the American Psychiatric
Association.
Dr. Silk worked for 20 years on
inpatient units. He became Chief, Adult
Services, at University of Michigan, in 1991 and
Associate Chair in 1994. He held both positions
until January of 2006.
Dr. Silk currently is doing PET
research, studying mu-opioid receptor activation
in patients with borderline personality disorder
in response to induced sadness (as a paradigm of
psychological pain) as well as in response to
physical pain. The findings in these studies
will be compared to the findings in depressed
outpatients. Dr. Silk has received funding from
the Borderline Personality Disorders Research
Foundation and the NIMH for these projects.
Dr. Silk has, throughout his
career, been an active clinician and teacher.
His primary interest has always been the
treatment and management of severely ill
patients and the problems that they present to
clinicians in the clinical arena.
|
|
|
|
Family Perspectives and
Family Connections: Family and Consumer Perspectives
|
| |
Perry D.
Hoffman, PhD
Perry D. Hoffman, Ph.D. is the President of the
National Education Alliance for Borderline
Personality Disorder (NEA-BPD) and on the
voluntary faculty of the Mount Sinai School of
Medicine. She is co-designer of the 12-week
education course for families, Family
Connections, which is available in many
locations both in the United States as well as
other countries. Dr Hoffman has several grants
from the National Institute of Mental Health (NIMH)
with a focus on families who have a relative
with borderline personality disorder. She is
also Co-Director of the five-year NIMH-funded
Family Perspectives on Borderline Personality
Conferences. Dr. Hoffman is a co editor, with
John G. Gunderson, MD, of the book
Understanding and Treating Borderline
Personality Disorder: A Guide for Professionals
and Family Members, published by the
American Psychiatric Press.
|
|
|
|
|
|
|
|
|
|
|
